The anti-allergic drug histaglobin inhibits NF-κB nuclear translocation and down-regulates proinflammatory cytokines

International Journal of Immunopharmacology

Volumn 22, Issue 10, 2000, Pages 755-763

  Ayoub, Mohamed ^a   Mittenbühler, Klaus ^a   Sütterlin, Bernd W ^b   Bessler, Wolfgang G ^a  

^a AG Tumorimmunologie/Vakzine Med F   (Germany)

^b Biobasal AG   (Switzerland)

Author keywords

Histaglobin; IL 1 ; IL 10; IL 6; Lipopeptide P3CSK4; NF B; TNF

Indexed keywords

ANTIALLERGIC AGENT; CYTOKINE; HISTAGLOBINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOPEPTIDE; PHYTOHEMAGGLUTININ; RECOMBINANT TUMOR NECROSIS FACTOR ALPHA; SELECTIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; GENE TRANSLOCATION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; LEUKOCYTE; MACROPHAGE; MONONUCLEAR CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANTI-ALLERGIC AGENTS; BONE MARROW CELLS; CELLS, CULTURED; CYTOKINES; DOWN-REGULATION; DRUG COMBINATIONS; FLUORESCENT ANTIBODY TECHNIQUE; GAMMA-GLOBULINS; HISTAMINE; HUMANS; INDICATORS AND REAGENTS; INTERLEUKIN-1; INTERLEUKIN-10; INTERLEUKIN-6; MONOCYTES; NF-KAPPA B; TRANSLOCATION, GENETIC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0343526915     PISSN: 01920561     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0192-0561(00)00037-0     Document Type: Article

References (39)

1. Liebhart J., Zak-Najmark T., Malolepszy J., Nadobna G., Liebhart E. Changes of histaminopexy in patients with bronchial asthma and chronic urticaria after histaglobin administration. Archivum Immunologiae et Therapiae Experimentalis. 3:(4):1986;385-389.
2. Gushchin I.S., Luss L.V., Il'ina N.I., Larina O.N., Pakhomova L.A. Therapeutic effectiveness of histaglobin preparations in patients with allergic rhinitis and chronic urticaria. Terapevticheskii Arkhiv. 71:(3):1999;57-62.
3. Paci A., Taddeucci-Brunelli G., Barachini P., Magliaccio P., Pierini G., Crimaldi G. Therapy of atopic dermatitis in childern. Study on the use of a desensitizing preparation. Pediatria Medicae Chirurgica. 8:(6):1986;839-844.
4. Parrot J.L., Laborde C. The histamine-fixing power of blood serum. Its modification after an injection of human serum or azoprotein of histamine. J. Physiol. 40:1951;885-889.
5. Ohnishi A., Watanabe K., Nakagawa T., Morita Y., Miyamoto T. Inhibitory effect of histamine-added human gammaglobulin on histamine release from human leucocytes. Clin. Immunol. 17:1985;1145-1150.
6. Ishikawa T., Shimada T., Kessoku N., Kiyoi M. Inhibition of rat mast cell degranulation and histamine release by histamine-rat gamma-globulin conjugate. International Archives of Allergy and Applied Immunology. 59:(4):1979;403-407.
7. Watanabe K., Ohnishi A., Seto Y., Kurimoto Y., Kiyoi M., Ishikawa T. Inhibitory effect of histamine-carried rat gamma globulin on histamine release from rat mast cells. Arerugi. 28:1979;666-673.
8. Yoshii H., Fukata-Yamazaki Y., Yamamoto K., Yago H., Yanagihara Y., Okudaira H. A complex of histamine/mouse γ-globulin preferentially inhibits allergen-induced peritoneal accumlation of eosinophils, but not neutrophils, in mice. J. Allegy & Clinical Immunology. 100:1997;809-816.
9. Hoffmann P., Wiesmüller K-H., Metzger J., Jung G., Bessler W.G. Induction of tumor cytotoxicity in murine bone-marrrow-derived macrophages by two synthetic lipopeptide analogues. Biol. Chem. Hopper-Seyler. 370:(6):1989;575-582.
10. Beranger F., Paterson H., Powers S., de Gunzburg, J., Hancock J.F. The effector domain of Rab6 plus a highly hydrophobic C terminus, is required for Golgi apparatus localization. Mol. Cell. Biol. 14:1994;744-758.
11. Pons I., Gras G., Courberand S., Benveniste O., Dormont D. Consequences of gamma-irradiation on inflammatory cytokine regulation in human monocytes/macrophages. International Journal of Radiation Biology. 71:(2):1997;157-166.
12. Baldwin A.S. Jr. The NF-κB and IκB proteins: new discoveries and insights. Annu. Rev. Immunol. 14:1996;649-681.
13. Belvisi M.G., Saunders M.A., Haddad El-B., Hirst S.J., Yacoub M.H., Barnes P.J., Mitchell J.A. Induction of cyclo-oxygenase-2 by cytokines in human cultured airway smooth muscle cells: novel inflammatory role of this cell type. British J. Pharmac. 120:(5):1997;910-916.
14. Viagano T., Habib A., Hernandez A., Bonazzi A., Boraschi D., Lebret M., Cassina E., Maclouf J., Sala A., Folco G. Cycloxygenase-2 and synthesis of PGF2 in human bronchial smooth-muscle cells. American Journal of Respiratory & Critical Care Medicine. 155:(3):1997;864-868.
15. Huang J.C., Liu D.Y., Yadollahi S., Wu K.K., Dawood M.Y. Interleukin-1β induces cyclooxygenase-2 gene expression in cultured endometrial stromal cells. Journal of Clinical Endocrinology & Metabolism. 83:(2):1998;538-541.
16. Akarasereenont P., Bakhle Y.S., Thiemermann C., Vane J.R. Cytokine-mediated induction of cyclo-oxygenase-2 by activation of tyrosine kinase in bovine endothelial cells stimulated by bacterial lipopolysaccharide. British J. Pharmac. 115:(3):1995;401-408.
17. 2D3 on acyl hydrolase and cyclooxygenase activities in IL-1β stimulated human synovial fibroblast cultures. Prostglandins Leukotrienes & Essential Fatty Acids. 55:(3):1996;191-194.
18. Dinarello C.A. Interleukin-1 and interleukin-1 antagonism. Blood. 77:(8):1991;1627-1652.
19. Dinarello C.A. Modalities for reducing interleukin activity in disease. Trends in Pharmacological Sciences. 14:(5):1993;155-159.
20. Eigler A., Sinha B., Hartmann G., Endres S. Taming TNF: strategies to restrain this proinflammatory cytokine. Immuno. Today. 18:(10):1997;487-492.
21. Mohler K.M., Torrance D.S., Smith C.A., Goodwin R.G., Stremler K.E., Fung V.P., Hadani H., Widmer M.B. Soluble tumor necrosis factor receptors are effective therapeutic agents in lethal endotoxemia and function simultaneously as both TNF carriers and TNF antagonists. J. Immunol. 151:1993;1548.
22. Enk A.H., Angeloni V.L., Udey M.C., Katz S. An essential role for Langerhans cell-derived IL-1β in the initiation of primary immune responses in skin. J. Immunol. 150:(9):1993;3968.
23. Suffredini A.F., Reda D., Banks S.M., Tropea M., Agosti J.M., Miller R. Effects of recombinant dimeric TNF receptors on human inflammatory response following intravenous endotoxin adminstration. J. Immunol. 155:1995;5038-5045.
24. Rogy M.A., Auffenberg T., Espat N.J., Philip R., Remick D., Wollenberg G.K., Copeland E.M., Moldawer L.L. Human TNF-R (p55) and IL-10 gene transfer in the mouse reduces mortality to lethal endotoxemia and also attenuates local inflammatory responses. J. Exp. Med. 181:1995;2289-2293.
25. McHugh S., Wilson A., Deighton J., Lachmann P., Ewan P. The profiles of IL-2, IL-6, and IFN-γ production in blood mononuclear cells from house-dust-mite-allergic patients: a role for IL-6 in allergic disease. Allergy. 49:(9):1994;751-759.
26. Suzuki Y., Saito H., Kasanuki J., Kishimoto T., Tamura Y., Yoshida S. Significant increase of IL-6 production in blood mononuclear leukocytes obtained from patients with active inflammatory bowel disease. Life Sciences. 47:(24):1990;2193-2197.
27. Gentile D., Dolye W., Whiteside T., Fireman P., Hayden F., Skoner D. Increased IL-6 levels in nasal lavage samples following experimental influenza A virus infection. Clinical & Diagnostic Laboratory Immunology. 5:(5):1998;604-608.
28. Ohkubo K., Ikeda M., Pawankar R., Gotoh M., Yagi T., Okuda M. Mechanisms of IL-6, IL-8 and GM-CSF release in nasal secretions of allergic patients after nasal challenge. Rhinology. 34:(4):1998;156-161.
29. Weimer L.K., Gamache D.A., Yanni J.M. Histamine-stimulated cytokine secretion from human conjunctival epithelial cells : inhibition by the histamine H1 antagonist emedastine. International Archives of Allergy & Immunology. 115:(4):1998;288-293.
30. Williams J.A., Shacter E. Regulation of macrophage cytokine production by prostaglandin E2. Distinct roles of cyclooxygenase-1 and -2. J. Biol. Chem. 272:(41):1997;25693-25699.
31. Wogensen L., Huang X., Sarvetnick N. Leukocyte extravasation into the pancreatic tissue in transgenic mice expressing IL-10 in the islets of Langerhans. J. Exp. Med. 178:1993;178-185.
32. Fiorentino D.F., Zlotink A., Vieira P., Mosmann T.R., Howard M., Moore K.W., O'Garra A. IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells. J. Immunol. 146:(10):1991;3444-3451.
33. de Waal Malefyt R., Haanen J., Spits H., Roncarolo M.G., Velde A., Figdor C., Johnson K., Kaselein R., Yssel H., de Vries J.E. Interleukin 10 and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression. J. Exp. Med. 174:1991;915-924.
34. Ito S., Ansari P., Sakatsume M., Dickensheets H., Vazquez N., Donnelly R., Larner A., Finbloom D. Interleukin-10 inhibits expression of both IFN-α- and IFN-γ-induced genes by suppressing tyrosine phosphorylation of STAT1. Blood. 93:(5):1999;1456-1463.
35. Teramoto T., Fukao T., Tashita H., Inoue R., Kaneko H., Takemura M., Kondo N. Serum IgE level is negatively correlated with the ability of peripheral mononuclear cells to produce IFN-γ: evidence of reduced expression of IFN-γ mRNA in atopic patients. Clinical & Experimental Allergy. 28:(1):1998;74-82.
36. Stacey M.A., Sun G., Vassalli G., Marini M., Bellini A., Mattoli S. The allergen Der p1 induces NF-κB activation through interference with IκB-α function in asthmatic bronchial epithelial cells. Biochem. Biophys. Res. Commun. 236:(2):1997;522-526.
37. Jourd'heuil D., Morise Z., Conner E.M., Kurose I., Grisham M.B. Oxidant-regulation of gene expression in the chronically inflammed intestine. Keio Journal of Medicine. 46:(1):1997;10-15.
38. Kopp E., Ghosh S. Inhibition of NF-κ B by sodium salicylate and aspirin. Science. 65:1994;956-959.
39. Grilli M., Pizzi M., Memo M., Spano P. Neuroprotection by aspirin and sodium salicylate through blockade of NF-κ B activation. Science. 274:(5):1996;1383-1385.